Bristol-Myers Squibb Company BMY
Set alert
63.02 USD +0.54 +0.86%
At close
62.88 -0.14 -0.22%
Pre-market · Nov 3, 4:35 AM ET
62.17 Day range 63.14
45.27 52-week range 68.64
- YTD
- +16.83%
- 1 year
- +36.94%
- Open
- 62.45
- Prev close
- 62.48
- Mkt cap
- 128.82B
- Vol
- 10.84M
- Avg vol
- 11.50M
- EPS
- 4.51
- P/E
- 13.97
- Div yield
- 4.03%
More statistics
- Low
- 62.17
- High
- 63.14
- Forward P/E
- 9.48
- Beta
- 0.19
- Short ratio
- 3.50
- Inst. own
- 84.78%
- Dividend
- 2.52
- Ex-div date
- Oct 1, 2026
- Earnings
- Feb 4, 2027
- 50-d avg
- 62.80
- 200-d avg
- 59.95
- 1y target
- 65.25
MAX chart
Events in this range
- Mar 3, 1997Split: 2 for 1
- Mar 1, 1999Split: 2 for 1
Signals (67)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | Dec 1, 2024 | 1 year ago |
| SMA: Bullish | Dec 1, 2024 | 1 year ago |
| SMA: Bearish | Sep 1, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 1, 2023 | 3 years ago |
| SMA: Bearish | Mar 1, 2023 | 3 years ago |
| SMA: Bullish | Dec 1, 2021 | 4 years ago |
| SMA: Bullish | Dec 1, 2021 | 4 years ago |
| MACD: Buy Signal | Dec 1, 2021 | 4 years ago |
| SMA: Bearish | Sep 1, 2021 | 5 years ago |
| SMA: Bearish | Sep 1, 2021 | 5 years ago |
| MACD: Sell Signal | Sep 1, 2021 | 5 years ago |
| MACD: Buy Signal | Mar 1, 2021 | 5 years ago |
| SMA: Bullish | Sep 1, 2019 | 7 years ago |
Newest 20 of 67.
Analyst view
Consensus: buy
Buy
Price target (mean) 65.25 +3.5% upside
Now 63.02
- Target (low)
- 40.00
- Target (mean)
- 65.25
- Target (high)
- 80.00
Ratings (0m) 28 10 buy · 17 hold · 1 sell
- Strong buy4
- Buy6
- Hold17
- Sell1
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.50 | 1.32 – 1.63 | 1.26 | +19.3% | 12.66B | +1.3% | 21 |
| Next quarter | 1.51 | 1.31 – 1.68 | 1.58 | -4.2% | 11.13B | -3.1% | 9 |
| Current year | 6.43 | 6.18 – 6.57 | 6.15 | +4.5% | 50.14B | +4.0% | 24 |
| Next year | 6.65 | 5.72 – 7.56 | 6.43 | +3.5% | 48.66B | -2.9% | 26 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Oct 26, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 13, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Oct 5, 2026 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Sep 16, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Sep 10, 2026 | HSBC | Maintained | Hold | Hold |
| Aug 5, 2026 | Argus Research | Upgrade | Hold | Buy |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 31, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jul 31, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 31, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Jul 10, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jul 6, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Apr 9, 2026 | B of A Securities | Maintained | Buy | Buy |
| Apr 8, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Apr 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Mar 17, 2026 | HSBC | Maintained | Hold | Hold |
| Feb 25, 2026 | RBC Capital | Initiated | — | Sector Perform |
| Feb 23, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 20, 2026 | Barclays | Initiated | — | Overweight |
| Feb 6, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 6, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 28, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 27, 2026 | Citigroup | Maintained | Neutral | Neutral |
